Delivery Order SPE2DB22D2005-SPE2DB24FJNV6
Award Date
6/14/24
Potential Completion Date
7/9/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The contract, valued at $5,015.10, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price...
The federal contract award summarized here is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency. The $1,687.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 4, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,141.08 and a completion date of July 5, 2024. It is a Firm Fixed Price Delivery Order contract, which means the price will not change regardless of Amerisourcebergen's costs. The contract does not have a set-aside designation, indicating it was competed on a full and open basis....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The award, valued at $1,570.54, is a Firm Fixed Price Delivery Order contract with a completion date of June 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,570.54, has a completion date of July 31, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC enables the DLA to...
This federal contract award is for the delivery of PROQUAD VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a firm fixed price of $1,570.54 and a completion date of May 21, 2024. It is a delivery order contract, not a set-aside...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The contract, valued at $3,141.08, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 2, 2024. This award is not associated with any set-aside designation. Amerisourcebergen...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $3,203.98 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is part of a larger...
This federal contract award is for the delivery of PROQUAD VIALS to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, Corporate Office Division. The contract has a ceiling value of $3,203.98 and a completion date of July 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on May 6, 2024 with a ceiling value of $12,564.32. The contract is a Firm Fixed Price Delivery Order with a completion date of May 28, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and has an Indefinite Delivery...